The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…

GlaxoSmithKline

GSK starts $175M plant to boost production of vaccine star Bexsero

GSK's vaccines access leads the pack, report says, as lagging Pfizer disputes findings